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AbstrAct
Background The association between periprocedural complications and the type of vascular access 
in patients treated with percutaneous coronary intervention (PCI) and rotational atherectomy (RA) has 
not been investigated as frequently as in an overall group of patients treated with PCI.
aims The aim of this study was to assess the associations between the type of vascular access and 
selected periprocedural complications in a group of patients treated with PCI and RA.
methods Based on a nationwide Polish registry (National Registry of Percutaneous Coronary Interventions 
[ORPKI]), we analyzed 536 826 patients treated with PCI between the years 2014 and 2018. The study 
included 2713 patients (0.5% of the overall group of patients treated with PCI [n = 536 826]) treated with 
PCI and RA. Among them, 1018 (37.5%) were treated via femoral access, and 1653 (60.9%) via radial access. 
Subsequently, these patients were subject to comparison, which was proceeded by propensity score 
matching.
results Following propensity score matching, multiple regression analysis revealed that patients 
undergoing PCI via femoral access experienced coronary artery perforation significantly less frequently 
than those managed via radial access (odds ratio, 0.29; 95% CI, 0.08–0.92; P = 0.04). We did not observe 
any significant associations between the type of vascular access and the periprocedural mortality rate 
(P = 0.99), cardiac arrest (P = 0.41), puncture ‑site bleeding (P = 0.99), allergic reaction (P = 0.32), myocardial 
infarction (P = 0.48), no ‑reflow phenomenon (P = 0.82), or the overall complication rate (P = 0.31).
conclusions In patients treated with PCI and RA, femoral access is associated with a lower rate of 
coronary artery perforations as compared with radial access.
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is maintained in cooperation with the Associa‑
tion of Cardiovascular Interventions of the Pol‑
ish Cardiac Society. The registry has been al‑
ready described elsewhere.2,3 The study cov‑
ered data obtained from the registry between 
January 2014 and December 2018. We selected 
2713 patients treated with PCI and RA out of 
536 826 undergoing PCI in the analyzed time 
interval. The technical aspects of the procedure, 
such as the choice of the access site, sheath size, 
and catheter size, were at the operator’s discre‑
tion. Furthermore, periprocedural anticoagula‑
tion and indications for PCI as well as the stent 
type remained at the first operator’s discretion. 
The protocol complied with the 1964 Declaration 
of Helsinki and all study participants provid‑
ed written informed consent to undergo a per‑
cutaneous intervention. Due to the retrospec‑
tive nature of the collected data and the regis‑
try, no ethics committee approval was required.
Endpoints Primary study endpoints included 
periprocedural complications such as death, car‑
diac arrest, puncture ‑site bleeding, allergic reac‑
tion, coronary artery perforation, myocardial in‑
farction, no ‑reflow phenomenon, and the over‑
all complication rate. The definitions of partic‑
ular complications were adopted in accordance 
with the applicable guidelines of the European 
Society of Cardiology, but the diagnosis of each 
complication was ultimately at the operator’s 
discretion.4 The overall complication rate was 
defined as the number of patients with at least 
1 of the periprocedural complications assessed.
statistical analysis Continuous variables 
were expressed as mean (SD) or median with 
the first and third quartiles, as appropriate. 
Nominal variables were presented as number 
and percentage. The study groups were com‑
pared using the t test for continuous variables 
or the χ2 test for nominal variables of their non‑
parametric equivalents, as appropriate. Stan‑
dardized differences were calculated for all base‑
line variables before and after matching. Out of 
all baseline demographic characteristics, those 
with a P value less than 0.2 or standardized dif‑
ferences higher than 10% for differences across 
the groups were included in the logistic regres‑
sion model used for propensity score matching. 
This was performed using the nearest ‑neighbor 
algorithm. The groups were considered balanced 
if standardized differences for each of the ana‑
lyzed baseline demographic characteristics were 
lower than 10%. The effects of femoral access 
on death, cardiac arrest, coronary artery per‑
foration, puncture ‑site bleeding, and no ‑reflow 
phenomenon were assessed using mixed ‑effect 
models to account for matching. Models were 
constructed with procedural data as covariates, 
aimed at adjustment. Statistical analysis was 
performed using the R software, version 3.5.3 
introduction The association between peri‑
procedural complications and long ‑term clinical 
outcomes depending on the femoral or radial ar‑
tery approach in the overall group of patients 
treated with percutaneous coronary interven‑
tions (PCIs) without rotational atherectomy (RA) 
has been widely investigated and the results of 
these studies were published.1 Nowadays, the ra‑
dial approach is preferred over femoral due to 
several advantages. Among others, it is associ‑
ated with fewer local complications, mainly in‑
cluding bleeding at the puncture site, and conse‑
quently with the possibility of faster discharge 
from the hospital.1 However, patients treated 
with PCI and RA comprise a specific population, 
which modifies the well ‑recognized spectrum 
of complications related to the type of vascu‑
lar access applied in those receiving percutane‑
ous treatment.2 Previous studies demonstrat‑
ed that selected periprocedural complications 
are linked to RA.2 The RA procedure was found 
to be an independent predictor of coronary ar‑
tery perforation (CAP) in the overall group of 
patients treated with PCI.2 In the era of a de‑
creasing aversion to radial access and its great‑
er popularity compared with the femoral ap‑
proach, even in patients at high periprocedural 
risk associated with undergoing complex percu‑
taneous revascularization procedures, we decid‑
ed to examine the differences in periprocedural 
complications regarding the vascular access site 
in this selected group of patients.3
The aim of the current study was to investigate 
the association between procedure ‑related compli‑
cations and the type of arterial approach (femoral 
versus radial) in patients treated with PCI and RA.
MEthods study design and patients This 
retrospective analysis was performed using 
prospectively collected data.2 These were ob‑
tained from the National Registry of Percuta‑
neous Coronary Interventions (ORPKI), which 
WhAt’s nEW?
The association between procedure ‑related complications and the type of vascular 
access in patients treated with percutaneous coronary interventions (PCIs) and 
rotational atherectomy (RA) has not been investigated as frequently as in an overall 
group of patients treated with PCI. Of note, studies of large patient groups are 
scarce. The type of vascular access may be associated with particular, sometimes 
even life ‑threatening, procedure ‑related complications. Therefore, based on 
a nationwide Polish registry (National Registry of Percutaneous Coronary 
Interventions [ORPKI]), we analyzed 536 826 patients treated with PCI. We found 
2713 patients treated with PCI and rotational atherectomy. After propensity score 
matching and multiple regression analysis, the main finding of this study was 
that femoral access was significantly less often related to coronary artery 
perforation compared with the radial approach. However, the frequency of 
coronary artery perforations remains low regardless of the type of vascular access, 
with the femoral approach being preferred in selected cases.
KEy Words
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coronary intervention, 
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(R Foundation for Statistical Computing, Vienna, 
Austria), with the following packages: MatchIt, 
version 3.0.2 and lme4, version 1.1‑21.
rEsults study population The study includ‑
ed 2713 patients treated with PCI and RA who 
were registered in the ORPKI database within 
the years 2014 to 2018. Among them, 1018 (37.5%) 
were treated via femoral access, and 1653 (60.9%) 
via radial access. In 42 patients (1.54%), other ap‑
proaches were used for PCI. Data regarding vas‑
cular access sites in the whole study group by 
the following years are shown in FIgURE 1.
Patient characteristics At baseline and before 
propensity score matching, the group of patients 
treated using the femoral approach was charac‑
terized by a greater burden of concomitant dis‑
eases and history of cardiovascular interventions. 
Table 1 Patient characteristics
Clinical variable Overall  
(n = 2671)
Radial  
(n [%], 1653 [61.9])
Femoral  
(n [%], 1018 [38.1])
P value
Age, y, mean (SD); median (IQR) 71.9 (9.59); 
72 (65–79)
71.85 (9.56); 
71 (65–79)
71.99 (9.64); 
72 (65–79.25)
0.7
Male sex 1801 (67.5) 1129 (68.5) 672 (66) 0.2
Hypertension 2005 (75.1) 1245 (75.3) 760 (74.7) 0.71
Diabetes 874 (32.7) 547 (33.1) 327 (32.1) 0.61
Prior cerebral stroke 116 (4.3) 78 (4.7) 38 (3.7) 0.24
Prior MI 1318 (49.3) 797 (48.2) 521 (51.2) 0.14
Prior PCI 1452 (54.4) 887 (53.7) 565 (55.5) 0.35
Prior CABG 358 (13.4) 202 (12.2) 156 (15.3) 0.02
Smoking 420 (15.7) 267 (16.1) 153 (15) 0.44
Psoriasis 7 (0.26) 6 (0.36) 1 (0.1) 0.26
Kidney disease 306 (11.5) 161 (9.7) 145 (14.2) <0.001
COPD 76 (3) 51 (3.2) 25 (2.7) 0.47
Clinical presentation Stable 
angina
1540 (57.9) 1023 (62.2) 517 (51.1) <0.001
Unstable 
angina
606 (22.8) 327 (19.9) 279 (27.6)
NSTEMI 301 (11.3) 171 (10.4) 130 (12.8)
STEMI 198 (7.45) 115 (7) 83 (8.2)
Other 12 (0.45) 9 (0.55) 3 (0.3)
Killip class I 732 (93.5) 463 (92.2) 269 (95.8) <0.001
II 38 (4.9) 32 (6.4) 6 (2.1)
III 8 (1) 7 (1.4) 1 (0.3)
IV 5 (0.6) 0 5 (1.8)
Data are presented as number (percentage) of patients unless otherwise indicated.
Abbreviations: CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; 
NSTEMI, non–ST ‑segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST ‑segment elevation 
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Figure 1 Particular types of vascular access (femoral, radial, and right radial) 
in patients undergoing percutaneous coronary intervention with rotational atherectomy 
in the years 2014 to 2018
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P = 0.41), or the overall complication rate (OR, 
0.73; 95% CI, 0.39–1.34; P = 0.31). Compared with 
the radial approach, the femoral approach was 
found to be one of the factors associated with 
the lower rate of CAPs (OR, 0.29; 95% CI, 0.08–
0.92; P = 0.04) (FIgURE 2).
discussion The main finding of this study 
was that patients undergoing percutaneous coro‑
nary revascularization with subsequent mechan‑
ical plaque modification with RA and in whom 
the radial approach was used are at greater risk 
of coronary artery perforation as compared with 
those managed via femoral access.
Patients treated with RA belong to a specific 
cohort of patients, usually with a high burden 
of concomitant disease. This particularly occurs 
in the case of calcium deposition in the arteri‑
al wall, which could be found more often in pa‑
tients with kidney failure, diabetes, previous cor‑
onary revascularizations, or at older age.5,6 This 
also applies to patients with multivessel diseases 
who are disqualified from cardiac surgery with 
bypass implantation.7 In this population, me‑
chanical lesion preparation plays a pivotal role 
and facilitates or, in a considerable percentage of 
cases, even enables percutaneous revasculariza‑
tion.8 The current European guidelines on RA in 
clinical practice suggest using any vascular ac‑
cess. They mainly focus on the possibility of per‑
forming the procedure considering the diameter 
of the guiding catheter that can be achieved de‑
pending on the type of access.9 This consensus 
pays less attention to the quality of the proce‑
dure or the risk of complications associated with 
RA itself, which can be life ‑threatening in cer‑
tain situations. It indicates that the main pre‑
dictors of coronary artery perforation include 
the burr size, the ratio of burr to vessel sizes, ar‑
tery tortuosity or the length of the calcified le‑
sion, and other indices of the culprit lesion and 
the artery.9 We could not include these parame‑
ters characterizing the culprit lesion and the tar‑
get vessel as well as the burr size, because the an‑
alyzed database did not contain such data. In our 
analysis, we concentrated on the available data 
and comparison of vascular access types. How‑
ever, expert opinions published in cooperation 
with the Association of Cardiovascular Inter‑
ventions of the Polish Cardiac Society draw at‑
tention to the link between the burr diameter 
and planned vascular access type.10 The authors 
suggested that radial access can be successful‑
ly used for smaller burr diameters, whereas for 
larger burr diameters, rarely implemented, a 7 Fr 
guiding catheter is needed. Despite using thin‑
‑walled sheaths, sheathless guiding catheters, or 
other maneuvers, it may be difficult to achieve 
radial access with such a diameter in many cas‑
es. Thin ‑walled sheaths enable clinicians to ap‑
ply 7 Fr guiding catheters to use radial access. In 
The difference reached statistical significance for 
prior coronary artery bypass grafting (P = 0.02) 
and kidney failure (P <0.001). The percentage of 
patients with unstable angina and myocardial 
infarction was also significantly higher in those 
treated via femoral access (P <0.001) (TABlE 1).
Procedural indices Considering the results of 
coronary angiography, patients treated via fem‑
oral access presented left main coronary artery 
involvement more frequently than those treated 
with the radial approach. However, these differ‑
ences were nonsignificant (P = 0.07). Neverthe‑
less, they were significant regarding the percent‑
age of patients in whom PCI was performed with‑
in the left main coronary artery. This occurred 
more often in those treated using the femoral ap‑
proach (P <0.001). Also, patients treated via fem‑
oral access were characterized by a significant‑
ly greater percentage of those treated with PCI 
within chronically occluded coronary arteries, 
which was reflected in the comparison of Throm‑
bolysis in Myocardial Infarction (TIMI) grades 
(P <0.001) and PCI within chronic total occlu‑
sions (P <0.001). Furthermore, the mean amount 
of contrast agent was greater in patients treat‑
ed using the femoral approach (P <0.001) (TABlE 2).
Periprocedural complications Before pro‑
pensity score matching, particular complica‑
tions were compared and no statistical signifi‑
cance was found for any comparison (TABlE 3). Al‑
though the rate of overall periprocedural com‑
plications was greater in patients treated via 
radial access compared with those in whom fem‑
oral access was used, it did not show statistical 
significance (2.9% vs 2.46%; P = 0.54). The dif‑
ference was mainly related to the higher rate of 
cardiac arrests (0.73% vs 0.59%; P = 0.8), CAPs 
(1.09% vs 0.49%; P = 0.13), and cerebral strokes 
(0.28% vs 0%; P = 0.55) in patients treated via 
radial access as compared with those managed 
using the femoral approach.
Propensity score matching After propen‑
sity score matching, the overall number of pa‑
tients decreased to 855 in each group. The com‑
parison of patients treated via femoral or radial 
access, after propensity score matching, is pre‑
sented in TABlE 4.
Predictors of periprocedural complications: 
vascular access Multivariate analysis re‑
vealed that the type of vascular access was not 
significantly associated with periprocedural 
mortality (P = 0.99), allergic reaction (P = 0.32), 
or puncture ‑site bleeding (P = 0.99) rates. No sig‑
nificant differences were also found for peripro‑
cedural myocardial infarction (odds ratio [OR], 
0.55; 95% CI, 0.09–2.78; P = 0.48), no ‑reflow phe‑
nomenon (OR, 1.2; 95% CI, 0.23–0.59; P = 0.82), 
cardiac arrest (OR, 0.62; 95% CI, 0.18–1.92; 
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Table 2 Procedural characteristics
Procedural index Overall 
(n = 2671)
Radial access 
(n = 1653 [61.9%])
Femoral access 
(n = 1018 [38.1%])
P value
Type of the culprit 
lesion
De novo 3716 (98.2) 2285 (98.3) 1431 (98) 0.48
Restenosis 58 (1.5) 32 (1.4) 26 (1.8) 0.32
Thrombosis 10 (0.03) 7 (0.3) 3 (0.2) 0.57
Site of the culprit 
lesion
Right coronary artery 1261 (33.3) 763 (32.8) 498 (34.1) 0.41
LMCA 301 (8) 155 (6.7) 146 (10) <0.001
LAD 1592 (42.1) 1030 (44.3) 562 (38.5) <0.001
Circumflex artery 596 (15.75) 353 (15.2) 243 (16.63) 0.23
Intermediate artery 32 (0.8) 22 (0.95) 10 (0.7) 0.39
Saphenous vein graft 2 (0.05) 1 (0.05) 1 (0.07) 0.74
Coronary 
angiography
SVD 725 (50.6) 472 (51.6) 253 (48.9) 0.7
MVD and no LMCA 494 (34.4) 325 (35.5) 169 (32.6)
MVD and LMCA 175 (12.2) 99 (10.8) 76 (14.7)
Separate LMCA 21 (1.5) 10 (1.1) 11 (2.1)
Other 19 (1.3) 10 (1.1) 9 (1.7)
TIMI grade 
before PCI
0 354 (13.6) 184 (11.6) 170 (16.9) <0.001
1 409 (15.8) 257 (16.2) 152 (15.1)
2 512 (19.7) 346 (21.8) 166 (16.5)
3 1318 (50.8) 801 (50.4) 517 (51.4)
TIMI grade after 
PCI
0 17 (0.65) 9 (0.56) 8 (0.8) 0.45
1 16 (0.61) 11 (0.68) 5 (0.5)
2 60 (2.3) 32 (2) 28 (2.8)
3 2515 (96.4) 1554 (96.7) 961 (95.9)
Thrombectomy 19 (0.71) 16 (0.97) 3 (0.29) 0.05
Chronic total occlusion 31 (5.82) 10 (3) 21 (10.55) <0.001
Bifurcation 58 (10.9) 38 (11.4) 20 (10.05) 0.62
Fractional flow reserve 13 (0.85) 11 (1.14) 2 (0.35) 0.14
Intravascular ultrasound 85 (5.56) 45 (4.7) 40 (7.05) 0.06
OCT 4 (0.26) 2 (0.21) 2 (0.35) 0.63
Type of PCI Drug ‑eluting stent 3521 (93.1) 2172 (93.5) 1349 (92.4) 0.21
Bare ‑metal stent 17 (0.4) 11 (0.5) 6 (0.4) 0.78
Bioresorbable 
scaffold
53 (1.4) 19 (0.8) 34 (2.3) <0.001
Other 193 (5.1) 122 (5.2) 71 (4.9) 0.59
Radiation dose, Gy, mean (SD); median 
(IQR)
1.59 (1.26); 
1.23 (0.71–2.07)
1.56 (1.26); 
1.21 (0.7–2.03)
1.64 (1.33); 
1.3 (0.75–2.13)
0.13
Contrast dose, ml, mean (SD); median 
(IQR)
210 (91.3); 
200 (150–250)
201.9 (80.7); 
200 (150–250)
223.5 (105.2); 
200 (150–270)
<0.001
Data are presented as number (percentage) unless otherwise indicated.
Abbreviations: IQR, interquartile range; LAD, left anterior descending artery; LMCA, left main coronary artery; MVD, multivessel 
disease; OCT, optical coherence tomography; SVD, single ‑vessel disease; TIMI, Thrombolysis in Myocardial Infarction; others, see TABlE 1
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Table 3 Procedure ‑related complications
Type of periprocedural 
complication
Overall 
(n = 2671)
Radial access 
(n [%], 1653 [61.9])
Femoral access 
(n [%], 1018 [38.1])
P value
Any 73 (2.73) 48 (2.9) 25 (2.46) 0.54
Death 5 (0.19) 4 (0.24) 1 (0.1) 0.65
MI 10 (0.37) 6 (0.36) 4 (0.39) <0.99
No ‑reflow phenomenon 12 (0.45) 7 (0.42) 5 (0.49) 0.77
Puncture ‑site bleeding 6 (0.22) 2 (0.12) 4 (0.39) 0.2
Cardiac arrest 18 (0.67) 12 (0.73) 6 (0.59) 0.8
Allergic reaction 3 (0.11) 2 (0.12) 1 (0.1) <0.99
CAP 23 (0.86) 18 (1.09) 5 (0.49) 0.13
Cerebral stroke 3 (0.27) 3 (0.42) 0 0.55
Dissection 3 (0.27) 2 (0.28) 1 (0.27) <0.99
Data are presented as number (percentage).
Abbreviations: CAP, coronary artery perforation; others, see TABlE 1
Table 4 Patient characteristics after propensity score matching analysis
Clinical variable Radial access (n = 855) Femoral access (n = 855) P value
Age, y, mean (SD) 71.57 (9.56) 91.98 (9.73) 0.38
Male sex 567 (67.1) 559 (66.2) 0.71
Weight, kg, mean (SD) 79.64 (15.71) 78.81 (14.87) 0.26
Hypertension 628 (74.3) 620 (14.9) 0.69
Diabetes 272 (32.2) 269 (31.8) 0.91
Prior cerebral stroke 40 (4.7) 33 (3.9) 0.47
Prior MI 436 (51.6) 439 (52) 0.92
Prior PCI 486 (57.5) 485 (57.4) 1
Prior CABG 124 (14.7) 129 (15.3) 0.78
Smoking 144 (17) 133 (15.7) 0.51
Kidney disease 115 (13.6) 126 (14.9) 0.48
Clinical presentation Stable angina 484 (57.3) 470 (55.6) 0.8
Unstable angina 235 (27.8) 245 (29)
NSTEMI 99 (11.7) 99 (11.7)
STEMI 22 (2.6) 28 (3.3)
Other 5 (0.6) 3 (0.4)
TIMI grade before PCI 0 107 (12.7) 151 (17.9) 0.001
1 120 (14.2) 122 (14.4)
2 183 (21.7) 132 (15.6)
3 435 (51.5) 440 (52.1)
TIMI grade after PCI 0 4 (0.5) 7 (0.8) 0.55
1 5 (0.6) 5 (0.6)
2 17 (2) 24 (2.8)
3 819 (96.9) 809 (95.7)
Data are presented as number (percentage) unless otherwise indicated.
Abbreviations: see TABlES 1 and 2
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turn, hydrophilic guiding catheters allow them 
to enter through the radial artery in certain sit‑
uations, eg, in interventions carried out in nar‑
row or constricted arteries. Expert opinions also 
emphasize the importance of coaxial guiding 
catheter positioning during PCI with RA.10 When 
catheter maneuvering is challenging, which of‑
ten occurs in the case of radial access, or when 
less stable catheters such as sheathless guiding 
catheters are used, coaxial positioning may be 
very difficult or even impossible in some patients. 
This can be a potential cause of a number of seri‑
ous complications, such as the release of embol‑
ic material into the aorta, looping and cutting 
the guidewire, or instability of the burr and sub‑
sequent possible CAP or even burr entrapment. 
One way to reduce the risk of releasing the em‑
bolic material into the aorta or the occurrence 
of possible complications associated with target 
artery rotablation is to use burrs and guiding 
catheters of smaller diameters, which is aimed 
at plaque modification rather than its debulk‑
ing. This method has recently gained a growing 
number of advocates. However, if burrs of small‑
er diameters are used, it may be problematic to 
sufficiently prepare the lesion for stent implan‑
tation. Inflations with cutting or high ‑pressure 
balloons can cause dissection, which is a con‑
traindication to RA, or modification of the ath‑
erosclerotic plaque inside the artery in a way 
that prevents stent delivery. This may occur de‑
spite applying a variety of techniques, including 
the use of the so ‑called mother ‑and ‑child cath‑
eters. Then, it may be necessary to repass RA, 
also with a burr of a larger diameter. Coronary 
artery perforation is another complication of in‑
sufficient lesion preparation by RA (due to too 
small burr diameters), which is a consequence of 
too aggressive attempts to prepare the lesion for 
implantation of the stent with various balloon 
catheters. All these factors indicate that one of 
the key elements that should be considered in 
order to successfully perform the RA procedure 
is to choose the right diameter of the guiding 
catheter, which would permit its stable coaxial 
positioning during RA. This could be often pro‑
vided only with the use of femoral access. How‑
ever, after considering a number of threats re‑
lated to this approach, radial access remains 
the first ‑choice option.10
In previous studies, the particular type of 
vascular access was not confirmed to be a pre‑
dictor of CAPs in an overall group of patients 
treated with PCIs.2,3 One of the recently pub‑
lished studies showed that RA was highly effec‑
tive and had a relatively low percentage of com‑
plications. However, it was associated with se‑
lected complications, which occurred more fre‑
quently than when the entire group of patients 
undergoing PCI without RA was analyzed.11 Con‑
sidering procedure ‑related complications, CAP 
was found to be the most typical one, excluding 
rotablation complications such as burr entrap‑
ment or breaking the burr. In one of the largest 
recent studies, it was reported that the frequen‑
cy of CAP in an overall group of patients treated 
with RA was 0.2%, that is, lower than in the pre‑
sented analysis, whereas the dissection rate was 
comparable and estimated at 0.3%.12 The mortal‑
ity rate of 0.2% reported in that study was also 
similar to our findings.12
Studies on procedure ‑related complications 
in patients treated with PCI and RA, which have 
been published so far, usually reported data 
on the entire course of hospitalization. That is 
why they demonstrated a higher frequency of 
these complications compared with the rates 
obtained in our analysis.13,14 Of note, the data 
published in this work relate only to complica‑
tions occurring in the catheterization laborato‑
ry, and not throughout the entire hospitaliza‑
tion. In addition, there is an issue of underesti‑
mating complications and not reporting them. 
However, in the latter case, this should not af‑
fect the general trends due to the large num‑
ber of patients observed. Nevertheless, a re‑
cent study showed that radial access did not 
cause inferior outcomes in long ‑term follow‑
‑up and was associated with shorter hospital‑
ization time and lower frequency of complica‑
tions related to the puncture site.13 Apart from 
that, the authors reported that the frequency 
of main adverse cardiac events during hospital‑
ization was almost 2‑fold higher in the group of 
patients treated via femoral access as compared 
with radial access (17.1% vs 8.9%; P = 0.33). This 
difference was mainly influenced by the high‑
er frequency of target lesion revascularizations. 
However, CAP rates were lower in the group of 
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Figure 2 The association between the type of vascular access (femoral versus radial) 
and the likelihood of a particular complication in patients treated with percutaneous coronary 
intervention and rotational atherectomy. Dots represent estimates (95% CIs), and lines, selected 
periprocedural complications.
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was observed is low, and percutaneous treat‑
ment seems to be far safer than surgical revas‑
cularization. Similarly, significantly less adverse 
events appear to be associated with puncture‑
‑site complications in the case of radial access, 
as compared with femoral, if advanced athero‑
sclerosis and significant calcification of the arte‑
rial walls are present. Of note, the frequency of 
hemorrhagic complications related to the punc‑
ture site is more than 3‑fold higher for femoral 
access as compared with the radial approach.
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patients treated via radial access (4.4% vs 7.3%; 
P = 0.57). That study was conducted on a small 
group of patients and used a retrospective de‑
sign.13 However, it showed that there are no 
consistent results and that they differ regard‑
ing the incidence of CAPs and other periproce‑
dural complications.
In the analyzed group, 3 periprocedural cere‑
bral strokes were found in the group of patients 
treated via radial access, while none were not‑
ed in those in whom femoral access was used. It 
can therefore be concluded that severely calci‑
fied atherosclerotic lesions in the aorta and the 
main arteries branching from the aortic arch, 
unsatisfactory intubation of the artery under‑
going RA, and burr instability may contribute 
to an increased number of adverse cerebrovas‑
cular events related to PCI. In another recent 
study, no differences in treatment outcomes 
were found between patients with advanced aor‑
tic calcifications and those without, and the fac‑
tors primarily determining follow ‑up progno‑
sis included the presence of valvular disease or 
comorbidities.15
strengths and limitations Undoubtedly, 
the large sample size is the greatest strength 
of the presented study, because analyses car‑
ried out in such a large group of patients under‑
going RA are rare. However, among numerous 
limitations of this study, the design of analysis 
should be addressed first. Our research was ret‑
rospective, carried out based on a registry con‑
taining prospectively collected data. The disad‑
vantages of such registry type include, but are 
not limited to, estimating the frequency of peri‑
procedural complications only during the proce‑
dure and during the early postprocedural period 
when the patient is still in the catheterization 
laboratory. Another important issue is the fact 
that recognizing periprocedural complications 
was at the operator’s discretion and depended 
on his or her knowledge, habits, or inclinations, 
which, unfortunately, imposes a bias. We could 
not analyze other well ‑recognized predictors of 
CAP in patients treated with rotablation, such 
as lesion and target vessel parameters charac‑
terizing the culprit lesion (length, diameter, 
site, tortuosity, bifurcations, trifurcation, etc), 
as well as the burr size or type of the rotablator 
guidewire, because the database did not contain 
such data. We also had no access to data regard‑
ing previous attempts of PCIs in the study pa‑
tients and the use of other typical devices, such 
as scoring, cutting, or high ‑pressure balloons. 
These missing facts could significantly modify 
results and cause some bias.
conclusions Femoral access, as opposed to ra‑
dial, is related to lower rates of CAPs in patients 
treated with PCI and RA. Nevertheless, the per‑
centage of patients treated with RA in whom CAP 
